KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $347.0 million.

  • Johnson & Johnson's Share-based Compensation rose 1762.71% to $347.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 1496.42%. This contributed to the annual value of $1.2 billion for FY2024, which is 120.48% up from last year.
  • Johnson & Johnson's Share-based Compensation amounted to $347.0 million in Q3 2025, which was up 1762.71% from $410.0 million recorded in Q2 2025.
  • In the past 5 years, Johnson & Johnson's Share-based Compensation registered a high of $410.0 million during Q2 2025, and its lowest value of $160.0 million during Q1 2021.
  • Its 5-year average for Share-based Compensation is $291.7 million, with a median of $296.0 million in 2023.
  • In the last 5 years, Johnson & Johnson's Share-based Compensation tumbled by 1834.86% in 2023 and then surged by 3370.79% in 2024.
  • Johnson & Johnson's Share-based Compensation (Quarter) stood at $259.0 million in 2021, then increased by 7.34% to $278.0 million in 2022, then plummeted by 35.97% to $178.0 million in 2023, then soared by 33.71% to $238.0 million in 2024, then soared by 45.8% to $347.0 million in 2025.
  • Its last three reported values are $347.0 million in Q3 2025, $410.0 million for Q2 2025, and $288.0 million during Q1 2025.